Innocell Autologous Cellular Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Innocell Autologous Cellular Immunotherapy, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer [Phase 1]